What is Edison?
Edison operates at the intersection of deep tech and life sciences, providing an AI-driven platform that automates the most labor-intensive aspects of scientific discovery. Its core product, Kosmos, leverages machine learning to perform hypothesis generation, data analysis, and molecular design. By automating these processes, Edison enables research institutions to achieve breakthroughs with unprecedented speed and precision. The company's market position is defined by its ability to transform traditional, manual research workflows into high-throughput, digital-first operations, making it a critical infrastructure provider for the next generation of scientific innovation.
How much funding has Edison raised?
Edison has raised a total of $70M across 1 funding round:
Seed
$70M
Seed (2025): $70M with participation from Striker Venture Partners, Susa Ventures, Spark Capital, Pillar VC, Olive Capital, Hawktail, and Triatomic Capital
Key Investors in Edison
Striker Venture Partners
A management firm based in San Francisco that provides venture capital services and strategic guidance to emerging businesses and growth-stage companies.
Susa Ventures
An early-stage venture capital firm that partners with seed-stage startups, providing capital and talent support to help build high-growth, unicorn-potential companies.
Spark Capital
A multi-stage investment firm with a presence in San Francisco, Boston, and New York, known for backing transformative products across various technology sectors.
What's next for Edison?
With this major enterprise-level funding, Edison is expected to scale its engineering and research teams to enhance the capabilities of the Kosmos platform. The strategic roadmap likely includes expanding the system's utility across diverse scientific domains, such as synthetic biology and advanced materials science. As the company transitions from its initial development phase to broader market adoption, the focus will shift toward establishing long-term partnerships with global research organizations and pharmaceutical entities. This capital provides the necessary runway to refine its proprietary algorithms and solidify its status as a leader in the burgeoning field of AI-augmented scientific discovery.
See full Edison company page
